It would be interesting to assess whether, in CRC pts, the frequency of CD15+ monocytes and their ratio with lymphocytes might correlate with patients’ clinical outcomes and thus represent a novel prognostic/predictive marker. The gene discussed is FUT4; the disease is colorectal carcinoma.